205 related articles for article (PubMed ID: 3541217)
1. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
2. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
Foon KA; Roth MS; Bunn PA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
[TBL] [Abstract][Full Text] [Related]
3. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
4. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
6. [Alpha interferon in the therapy of cutaneous T cell lymphomas].
Lang MH; Altmeyer P; Lodemann E; Holzmann H
Z Hautkr; 1986 May; 61(9):599-608. PubMed ID: 3487184
[TBL] [Abstract][Full Text] [Related]
7. Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
Foss FM
Semin Oncol; 2000 Apr; 27(2 Suppl 5):58-63. PubMed ID: 10877054
[TBL] [Abstract][Full Text] [Related]
8. Alpha interferon in the treatment of hematologic malignancies.
Roth MS; Foon KA
Am J Med; 1986 Nov; 81(5):871-82. PubMed ID: 3535496
[TBL] [Abstract][Full Text] [Related]
9. [Interferon-alpha in the treatment of hematologic neoplasms].
Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
[TBL] [Abstract][Full Text] [Related]
10. [Current therapy concepts in cutaneous T-cell lymphomas].
Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
[TBL] [Abstract][Full Text] [Related]
11. [Gamma interferon therapy of cancer patients].
Kobayashi Y; Urabe A
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):804-9. PubMed ID: 3133983
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Int J Cancer Suppl; 1987; 1():9-13. PubMed ID: 3305390
[TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon in the treatment of nodular lymphomas.
Urba WJ; Longo DL
Semin Oncol; 1986 Dec; 13(4 Suppl 5):40-7. PubMed ID: 3541218
[TBL] [Abstract][Full Text] [Related]
14. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+].
Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Schwarzenberg L; Machover D; Ribaud P; de Vassal F
Biomed Pharmacother; 1982 Mar; 36(2):112-6. PubMed ID: 7126777
[TBL] [Abstract][Full Text] [Related]
18. Interferon in the treatment of cutaneous T-cell lymphoma.
Olsen EA; Bunn PA
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1089-107. PubMed ID: 8522486
[TBL] [Abstract][Full Text] [Related]
19. Recombinant leukocyte A interferon in B-cell chronic lymphocytic leukemia: in vivo effects on autologous antitumor immunity.
Schulof RS; Lloyd MJ; Stallings JJ; Mai D; Phillips TM; Jones GJ; Schechter GP
J Biol Response Mod; 1985 Jun; 4(3):310-23. PubMed ID: 3874930
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]